Brenda Hefti's most recent trade in Exelixis Inc was a trade of 6,625 Common Stock done at an average price of $50.2 . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 50.21 per share. | 15 May 2026 | 6,625 | 106,762 (0%) | 0% | 50.2 | 332,641 | Common Stock |
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.10 per share. | 15 May 2026 | 6,411 | 113,387 (0%) | 0% | 51.1 | 327,602 | Common Stock |
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 23,119 | 119,631 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 15 Feb 2026 | 18,669 | 96,512 (0%) | 0% | 44.0 | 821,623 | Common Stock |
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.92 per share. | 15 Feb 2026 | 5,430 | 115,181 (0%) | 0% | 43.9 | 238,486 | Common Stock |
| Exelixis Inc | Dr. Brenda Hefti, J.D.,PhD | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2025 | 30,170 | 120,611 (0%) | 0% | 0 | Common Stock |